Abstract
Xenobiotic glucuronidation represents a major metabolic protection of the brain against chemical aggressions at blood-brain interfaces. We previously observed that glucuronidation of 1-naphthol was very effective in olfactory bulb, which is a pathway for the entry of foreign molecules into the brain. In this work, we showed that 1-naphthol glucuronidation varied according to age. It was very high at birth, then decreased markedly in 3-month-old rats and increased again significantly during aging. By Western blot and reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated the presence in the olfactory bulb of the UDP-glucuronosyltransferase (UGT) 1A6 isoform, which catalyzes the glucuronidation of phenols, such as 1-naphthol. Quantitative RT-PCR indicated that the mRNA levels encoding UGT1A6 did not significantly change according to age, thus suggesting that other differently regulated UGT isoforms were present and would account for the variations of 1-naphthol glucuronidation observed.
Similar content being viewed by others
REFERENCES
Lazard, D., Zupko, K., Poria, Y., Nef, P., Lazarowictz, J., Horn, S., Khen, M., and Lancet, D., 1991. Odorant signal termination by olfactory UDP-glucuronosyltransferase. Nature 349:790–793.
Pardridge, W. M., 1991. Transnasal and intraventricular delivery of drugs. Pages 99–122, in Pardridge, W. M. (ed.), Peptide Drug Delivery to the Brain. Raven Press, New York.
Hastings, L., Evans, J. E., 1991. Olfactory primary neurons as a route of entry for the toxic agents into the CNS. Neurotoxicology 12:707–714.
Mulder, G. J., 1992. Glucuronidation and its role in regulation of biological activity of drugs. Ann. Rev. Pharmacol. Toxicol. 32:25–49.
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Bélanger A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Roy-Chowdhury, J., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F., Nebert, D. W., 1997. The UDP-glucuronosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269.
Tephly, T. R., Coughtrie, M. W. H., 1989. UDP-glucuronosyltransferases: a family of detoxifing enzymes. Trends Pharm. Sci. 11:276–279.
Kroemer, H. K., Klotz, U., 1992. Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin. Pharmacokinet. 23:292–310.
Leininger, B., Ghersi-Egea, J. F., Siest, G., Minn, A., 1991. In vivo study of the elimination from brain tissue of an intracerebrally-formed xenobiotic metabolite, 1-naphthyl-β-D-glucuronide. J. Neurochem. 56:1163–1168.
Ghersi-Egea, J. F., Minn, A., Siest, G., 1988. A new aspect of the protective functions of the blood-brain barrier: Activities of four drug-metabolizing enzymes in isolated brain microvessels. Life Sci., 42:2515–2523.
Leininger-Muller, B., Ghersi-Egea, J. F., Siest, G., Minn, A., 1994. Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci. Lett. 17:537–40.
Minn, A., Ghersi-Egea, J. F., Perrin, R., Leininger, B., Siest, G., 1991. Drug metabolizing enzymes in the rat brain and brain microvessels. Brain Res. Rev. 16:65–82.
Ghersi-Egea, J. F., Leininger-Muller, B., Suleman, G., Siest, G., Minn, A., 1994. Localization of several drug-metabolizing enzymes activities in blood-brain interface structures. J. Neurochem. 62:1089–1096.
El-Bachá, R. D. S., Minn, A. 1999. Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain. Cell. Mol. Biol. 45:15–23.
Coughtrie, M. W. H., Burchell, B., Leakey, J. E. A., Hume, R., 1988. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol., 34:729–735.
Delpech, I., Kiffel, L., Magdalou, J., Siest, G., Martin, P., Bouchy, M., Andre, J. C., 1984. Structural changes of liver microsomes in rat during neonatal life: influence on the glucuronidation rates of various substrates. Biochem. Biophys. Res. Comm. 119:29–34.
Ghersi-Egea, J. F., Walther, B., Decolin, D., Minn, A., Siest, G., 1987. The activity of 1-naphthol-UDP-glucuronosyltransferase in the brain. Neuropharmacology 26:367–372.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., Randall, R. J., 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265–275.
Chat, M., Bayol-Denizot, C., Suleman, G., Roux, F., Minn A., 1998. Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells. Life Sci., 62:151–163.
Chomczynski, P., Sacchi, N., 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156–159.
Khiri, H., Reynier, P., Peyrol, N., Lerique, B., Torresani, J., Planells, R., 1996. Quantitative multistandard RT-PCR assay using interspecies polymorphism. Mol. Cell. Probes, 10:201–211.
Reuter, S. F., Vasiliou, V., Puga, A., and Nebert, D. W., 1994. Characterization of the murine dioxin-inducible UDP glucuronosyltransferase (Ugt1-06) gene. Toxicologist, 14:410–410.
Ponte, P., Ng, S. Y., Engel, J., Gunning, P., Kedes, L., 1984. Evolutionary conservation in the untranslated regions of actin mRNAs:DNA sequence of a human beta-actin cDNA. Nucleic Acids Res., 12:1687–1696.
Grillasca, J. P., Gastaldi, M., Khiri, H., Dace, A., Peyrol, N., Reynier, P., Torresani, J., Planells R., 1997. Cloning and initial characterization of human and mouse Spot 14 genes. FEBS Lett., 401:38–42.
Chien, Y. W., Chang, S. F., 1987. Intranasal drug delivery for systemic medications. Crit. Rev. Ther. Drug Carrier Syst. 42:67–194.
Thorne, R. G., Emory, C. R., Ala, T. A., Frey, W. H., 1995. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res. 692:278–282.
Naylor, J. L., Widdowson, P. S., Simpson, M. G., Farnworth, M., Ellis, M. K., Lock, E. A., 1995. Further evidence that the blood-brain barrier impedes paraquat entry into the brain. Human Experim. Toxicol. 14:587–594.
Das, M., Seth, P. K., Dixit, R., Mukchtar, H., 1982. Aryl hydrocarbon hydroxylase of rat brain mitochondria: properties of, and effect of inhibitors and inducers on, enzyme activity. Arch. Biochem. Biophys., 217:205–215.
Iscan, M., Reuhl, K., Weiss, R., Maines, M. D., 1990. Regional and subcellular distribution of cytochrome P450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem. Biophys. Res. Com., 169:858–863.
Talamo, B. R., Rudel, R. A., Kosik, K. S., Lee, V. M. Y., Neff, S., Adelman, L., Kauer J. S., 1989. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 337:736–739.
Miller, S., Coopersmith, R., Leon, M., 1991. Biochemical quantitation and histochemical localization of glucose 6-phosphate dehydrogenase activity in the olfactory system of adult and aged rats. Neurochem. Res. 16:475–481.
Emi, Y., Ikushiro, S., Iyanagi, T., 1995. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. (Tokyo) 117:392–399.
Suleman, F. G., Abid, A., Gradinaru, D., Daval, J. L., Magdalou, J., and Minn, A., 1998. Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch. Biochem. Biophys., 62:151–163.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gradinaru, D., Suleman, F.G., Leclerc, S. et al. UDP-Glucuronosyltransferase in the Rat Olfactory Bulb: Identification of the UGT1A6 Isoform and Age-Related Changes in 1-Naphthol Glucuronidation. Neurochem Res 24, 995–1000 (1999). https://doi.org/10.1023/A:1021048525012
Issue Date:
DOI: https://doi.org/10.1023/A:1021048525012